The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes

Clinical Immunology

Volumn 124, Issue 1, 2007, Pages 90-97

  Han, Shu fang ^a   Liu, Peng ^b   Zhang, Wei ^a   Bu, Lun ^a   Shen, Min ^a   Li, Hu ^a   Fan, Yan hong ^a   Cheng, Kang ^a   Cheng, He xiang ^a   Li, Cheng xiang ^a   Jia, Guo liang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Destabilization; Immunity; Lymphocytes

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CD4+ CD25+ FOXP3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STABLE ANGINA PECTORIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; CD4-POSITIVE T-LYMPHOCYTES; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS;

EID: 34250628384     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.03.546     Document Type: Article

References (35)

1. Getz G.S. Immune function in atherogenesis. J. Lipid Res. 46 (2005) 1-10
2. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 (2005) 1685-1695
3. Liuzzo G., Gorozy J.J., Yang H.Y., et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 102 (2000) 2883-2888
4. Soejima H., Irie A., Miyamoto S., et al. Preference toward a T-helper type 1 response in patients with coronary spastic angina. Circulation 107 (2003) 2196-2200
5. Mallat Z., Gojova A., Brun V., et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108 (2003) 1232-1237
6. Methe H., Brunner S., and Wiegand D. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J. Am. Coll. Cardiol. 45 (2005) 1939-1945
7. Nakajima T., Schulte S., Warrington K.J., et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 105 (2002) 570-575
8. Valgimigli M., Agnoletti L., Curello S., et al. Serum from patients with acute coronary syndromes displays a proapoptotic effect on human endothelial cells. Circulation 107 (2003) 264-270
9. Daugherty A., and Rateri D.L. T lymphocytes in atherosclerosis: the yin-yang of Th1 and Th2 influence on lesion formation. Circ. Res. 90 (2002) 1039-1040
10. Potteaux S., Esposito B., Oostrom O., et al. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1474-1478
11. Caligiuri G., Groyer E., Khallou-Laschet J., et al. Reduced immunoregulatory CD31+ T cells in the blood of atherosclerotic mice with plaque thrombosis. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1659-1664
12. Shevach E.M. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18 (2000) 423-449
13. Binder C., Chang M., Shaw P., et al. Innate and acquired immunity in atherogenesis. Nat. Med. 8 (2002) 1218-1226
14. Veillard N.R., Steffens S., Burger F., et al. Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2339-2344
15. Sakaguchi S. Regulatory T cells: key controllers of immunologic self tolerance. Cell 101 (2000) 455
16. Shevach E.M. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18 (2000) 423
17. Piccirillo C.A., and Shevach E.M. Cutting edge: control of CD8+T cell activation by CD4+CD25+ immunoregulatory cells. J. Immunol. 167 (2001) 1137
18. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., and Enk A.H. Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193 (2001) 1285
19. Sakaguchi S., Toda M., Asano M., et al. T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases. J. Autoimmun. 9 (1996) 211
20. Ait-Oufella H., Salomon B., Potteaux S., et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12 (2006) 178-180
21. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004) 531-562
22. Jonuleit H., Schmitt E., Stassen M., et al. Identification and functional characterization of human CD4+CD25+T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193 (2001) 1285-1294
23. Morgan M.E., Flierman R., van Duivenvoorde L.M., et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 52 (2005) 2212-2221
24. Denning T.L., Kim G., and Kronenberg M. Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J. Immunol. 174 (2005) 7487-7491
25. Kukreja A., Cost G., Marker J., et al. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109 (2002) 131-140
26. Ehrenstein M.R., Evans J.G., Singh A., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200 (2004) 277-285
27. Viglietta V., Baecher-Allan C., Weiner H.L., et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199 (2004) 971-979
28. Crispin J.C., Martinez A., and Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 21 (2003) 273-276
29. Rezvani K., Mielke S., Ahmadzadeh M., et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108 (2006) 1291-1297
30. Walker M.R., Kasprowicz D.J., Gersuk V.H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25+T cells. J. Clin. Invest. 112 (2003) 1437-1443
31. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
32. Mor A., Luboshits G., Planer D., et al. Altered status of CD4+CD25+ regulatory T cells in patients with acute coronary syndromes. Eur. Heart J. 27 (2006) 2530-2537
33. Elhage R., Gourdy P., Brouchet L., et al. Deleting TCRαβ+ or CD4+T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficiency mice. Am. J. Pathol. 165 (2004) 2013-2018
34. Kryczek I., Wei S., Zou L., et al. Induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J. Immunol. 177 (2006) 40-44
35. Taylor J., Mohrs M., and Pearce E. Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the effector population. J. Immunol. 176 (2006) 5839-5847